Offstream
news

At an Alzheimer's Association conference in Amsterdam, Netherlands, experts in Alzheimer's disease propose a new seven-point diagnostic scale that incorporates advancements in testing for key Alzheimer's-related proteins and aims to facilitate more personalized treatment strategies.
2023-07-16

The U.S. Food and Drug Administration approves the use of aducanumab to treat Alzheimer's disease, the first Alzheimer's drug to be approved in 18 years and the first to target the disease process. The drug is considered controversial as clinical trials gave conflicting results on its effectiveness.
2021-06-7

Pharmaceutical company Pfizer discontinues research into treating patients with Alzheimer's disease and Parkinson's disease. [https:--www.telegraph.co.uk-science-2018-01-08-hunt-alzheimers-cure-suffers-heavy-blow-pfizer-pulls-research- "(The Telegraph)" ]
2018-01-8

Biogen Idec Inc. reports that a drug in a phase II clinical research trial has achieved the first experimental demonstration of a statistically significant reduction in amyloid plaque as well as a slowing of clinical impairment in patients with Alzheimer's disease. The antibody drug, aducanumab, blocked beta amyloid formation, a protein that forms toxic brain-destroying plaques, and significantly slowed cognitive decline.
2015-03-20

A group of American scientists at Washington University announce in a study published in the journal "Neuron" that they have identified a number of genetic markers that are associated with increased risk of Alzheimer's disease.
2013-04-4

Research by study author Kerry O'Banion, of the University of Rochester Medical Center in Rochester, New York, announces that a particularly harmful type of space radiation may accelerate the development of Alzheimer's disease.
2012-12-31

British entertainer Max Bygraves, who had been suffering from Alzheimer's disease, dies in Hope Island, Queensland, Australia, at the age of 89.
2012-08-31

The United States announces a national plan to develop an effective treatment for Alzheimer's disease by 2025.
2012-05-15